Site Map  |  Careers  |  Contact   May 08, 2009 Teikoku Pharma USA Acquires Travanti Pharma Inc. March 09, 2009 Teikoku Pharma USA and Eisai Co., Ltd Announce Licensing Agreement for a New 7-Day Transdermal Formulation of donepezil. Teikoku Seiyaku Co. has been in the pharmaceutical business over 150 years and built its reputation on trusted, high-quality products. Read more At Teikoku, we expand our product portfolio through licensing and partnerships with leading pharmaceutical companies around the world. Read more Teikoku offers the latest in drug delivery technologies, including oral jellies, transdermal hydrogel patches and transmucosal patches. Read more Copyright © 2006 Teikoku Pharma USA, Inc. All Rights Reserved. Teikoku Pharma USA, Teikoku, Teikoku Pharma, Teikoku Seiyaku Co., drug delivery systems, TDS, patches, unit-dose jellies, unit-dose liquids, creams and ointments, delivery products, pain management, cosmetic care, TDS technologies, patent protections, prescription, otcs, medical device market, applications, transdermal drug delivery technologies, Lidoderm, Endo Pharmaceuticals, post-herpetic neuralgia, TDS-based health and beauty products, face masks, anti-wrinkle patches, skin whiteners, and cuticle softe